store at low temperature
store at -20°C
Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 80,000 |
5 mg | 在庫あり | ¥ 200,500 |
10 mg | 在庫あり | ¥ 319,000 |
25 mg | 在庫あり | ¥ 454,500 |
50 mg | 在庫あり | ¥ 638,000 |
100 mg | 在庫あり | ¥ 861,000 |
説明 | Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia. |
In vivo | Bococizumab (0, 10, 30, and 100 mg/kg; i.v.; Pregnant Sprague-Dawley (SD) rats) decreases maternal and fetal cholesterol and shows good tolerance and no effects on ovarian or uterine parameters.[2] |
別名 | RN316, PF-04950615 |
分子量 | N/A |
CAS No. | 1407495-02-6 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bococizumab 1407495-02-6 Others RN316 PF 04950615 RN-316 PF-04950615 PF04950615 RN 316 Inhibitor inhibitor inhibit